GREY:IPHAF - Post by User
Post by
claritason Jul 22, 2008 8:40am
775 Views
Post# 15315892
RBC target drops to $0.15
RBC target drops to $0.15Analyst believes 'prospects are slim for ISA'
Also states 'we believe it is possible that a small to mid-sized player may be interested in voclosporin although we expecxt it to be challenging for a small to mid-sized player to compete from a marketing perspective'.
They expect ISA to minimize the burn rate as much as possible to conserve cash. RBC extimates that ISA has about $0.15 in cash value as of end of July. WIth the working capital loan this adds up to $0.27.
The market was right again. Wonder who had the inside scoop that the results were not good enough.